AstraZeneca Widens Covid Vaccine Access in $750 Million Deal (1)

AstraZeneca Plc entered a $750 million deal to broaden global access to one of the fastest-moving experimental Covid-19 vaccines, should it be successful.

The British drugmaker reached an agreement with the Coalition for Epidemic Preparedness Innovations and Gavi, the Vaccine Alliance, to support the manufacturing, procurement and distribution of 300 million doses of the shot, according to a statement Thursday. Delivery will start by the end of the year.

In addition, the company reached a licensing agreement with the Serum Institute of India to supply 1 billion doses for low- and middle-income countries, with a commitment to provide 400 million ...